Description

Our Transformation Talks Summer Special is here!

Tune in to learn about risks and challenges in developing a Next-Generation Therapy (NGT), bringing it to the market, and how NGTs can change patients’ lives once their value is understood and correctly attributed by the decision makers / payers.

Meet our speakers:

• Andrea Mantovani – Vice President, Global Market Access and Pricing, Alira Health
• Oswald Bentinck - Vice President - Head of Market Access EMEA, Novartis Gene Therapies
• Pietro Sternini - Executive Director, Gene Therapy Market Access & Marketing Lead, EMEA, Astellas Gene Therapies

Meet our host:

Kenny Carberry – Director, Clinical Development, Alira Health

This episode is also available in video format, check it out on our YouTube channel: https://youtu.be/u-ThcNNc7Uk

Download this episode's handouts here.